There are two entirely different numbers behind the phrase tirzepatide dosing. One is the milligram schedule used in the clinical trials — start low, escalate every four weeks, hold at a maintenance step. The other is the mg/mL concentration you create when you reconstitute a vial. Confusing them is the most common error in this compound, and it is worth five minutes to keep them apart.
Quick Breakdown: Tirzepatide Dosing at a Glance
Quick Answer: In the trial programme, tirzepatide is dosed once weekly, starting at 2.5 mg and escalating in 2.5 mg steps every four weeks — 5, 7.5, 10, 12.5, up to 15 mg — until the assigned maintenance dose is reached. At the bench, "dosing" means the concentration you set by adding diluent: a 20 mg vial in 2 mL is 10 mg/mL, which is 100 mcg per unit on a U-100 syringe.| Term | What It Means | Where You See It |
|---|---|---|
| Dose (mg) | Mass of peptide in one administration. | Trial protocols, published papers. |
| Concentration (mg/mL) | Peptide dissolved per millilitre of diluent — set entirely by you. | Reconstitution, calculator output. |
| Syringe units | Tick marks on a U-100 syringe; 100 units = 1 mL. | Bench work, protocol logs. |
| Titration | Stepping the dose up every four weeks instead of starting at target. | Trial design, and why GI effects cluster at increases. |
The Trial Schedule, Plainly
Tirzepatide's escalation ladder is well documented because it was built into the trial design:
- Starting dose: 2.5 mg weekly. A tolerance step, not a therapeutic target.
- Escalation: 2.5 mg every four weeks. 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg.
- Maintenance: the highest dose tolerated without unacceptable GI effects, held steady.
- Why four weeks: long enough for the gut to adapt at each step. Faster escalation does not produce faster results — it produces more nausea.
The published detail behind each step is in the tirzepatide mechanism and trial overview. What matters at the bench is that the trial schedule describes milligrams delivered, not concentrations created.
From Vial to Syringe: The Reconstitution Maths
A vial contains mass, not a dose. Three numbers govern the conversion:
- Mass in the vial — printed on the label, in milligrams.
- Diluent added — your choice, recorded in millilitres.
- Syringe calibration — U-100 means 1 mL = 100 units, so 1 unit = 0.01 mL.
| Vial | Diluent | Concentration | Per Unit (U-100) |
|---|---|---|---|
| 20 mg | 2.0 mL | 10 mg/mL (10,000 mcg/mL) | 100 mcg per unit |
| 30 mg | 2.0 mL | 15 mg/mL (15,000 mcg/mL) | 150 mcg per unit |
| 40 mg | 2.0 mL | 20 mg/mL (20,000 mcg/mL) | 200 mcg per unit |
| 40 mg | 4.0 mL | 10 mg/mL (10,000 mcg/mL) | 100 mcg per unit |
The pattern: doubling the diluent halves the concentration and doubles the volume for the same mass. If a target draw lands on two or three units, the concentration is too high to measure accurately — add more diluent. The full walkthrough is in how much bacteriostatic water to add, and the Peptide Calculator does it for any vial.
Matching Vial Size to Your Weekly Amount
Because vials are priced per milligram and dosing is weekly, the right vial is the one that finishes inside the 28-day window after reconstitution rather than one that sits in the fridge:
| Weekly Amount | Per 4 Weeks | Vial That Fits | Price |
|---|---|---|---|
| 2.5 mg | 10 mg | 20 mg (spans 8 weeks) | $80 |
| 5 mg | 20 mg | 20 mg (exactly 4 weeks) | $80 |
| 7.5 mg | 30 mg | 30 mg (exactly 4 weeks) | $110 |
| 10 mg | 40 mg | 40 mg (exactly 4 weeks) | $130 |
Our tirzepatide vials come in 20, 30 and 40 mg, priced $80, $110 and $130 respectively — $4.00, $3.67 and $3.25 per milligram.
Reconstitution Practice That Affects the Numbers
- Use preserved diluent. Standard practice is bacteriostatic water, which suppresses microbial growth across repeated draws.
- Add diluent down the glass wall. Spraying onto the cake under vacuum creates foam and incomplete dissolution — your concentration is wrong before you draw anything.
- Record what you actually added. Vial mass, diluent volume and puncture date. Every downstream calculation depends on it.
- Never adjust concentration to fix a measurement error. Re-check the arithmetic instead.
Frequently Asked Questions
What is the difference between tirzepatide dosing and dosage?
Nothing — the terms are interchangeable in the literature and in search. We treat them as one topic.
What dose do the trials use?
Weekly, starting at 2.5 mg and escalating in 2.5 mg steps every four weeks up to 15 mg, with the maintenance dose set by tolerance. Those figures belong to the trial protocols, not to a research vial.
How do I convert milligrams to syringe units?
Mass ÷ diluent volume = mg/mL. Multiply by 1,000 for mcg/mL, divide by 100 for mcg per unit. The table above does it for common vial sizes.
Does more diluent make the solution stronger?
No — the opposite. Mass is fixed; more diluent means lower concentration and a larger volume for the same mass.
How much does tirzepatide cost per month?
At 5 mg a week, a 20 mg vial at $80 covers four weeks. Pharmacy tirzepatide runs $325.67–$650 a month for the same period. See our Canadian pricing breakdown.
Calculate Before You Reconstitute
Enter your vial strength, diluent volume and target amount — the Peptide Calculator returns the exact syringe units so you are not converting in your head at the bench. Open the Peptide Calculator →Premium Collection
Explore selected research products.
✓ COA
✓ COA
Somatropin Human Growth Hormone (HGH) 10-Vial Kit
✓ COA
Free resource
New to peptide research?
The free 51-page guide covers 12 compound profiles, reconstitution math, COA reading and storage — without the hype.
Get the free guide →Or start with the 2-page checklist